Clinical Trial Update: A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of RS001 in relapsed/refractory B-cell malignancies, including B-cell Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia, is liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• RS001

Snippet

Sponsor: Guangdong Ruishun Biotech Co., Ltd | Conditions: B-cell Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | Status: NOT_YET_RECRUITING